General Information of Drug (ID: DMVQI2A)

Drug Name
APH-1104 Drug Info
Indication
Disease Entry ICD 11 Status REF
Alzheimer disease 8A20 Phase 1 [1]
Cross-matching ID
TTD Drug ID
DMVQI2A

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Drug(s) Targeting Alpha-secretase (ASE)
Drug Name Drug ID Indication ICD 11 Highest Status REF
ID1201 DM3LHAX Alzheimer disease 8A20 Phase 2 [2]
APH-1105 DMT2IWF Alzheimer disease 8A20 Phase 2 [3]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Alpha-secretase (ASE) TTBH0LA NOUNIPROTAC Modulator [1]

References

1 Clinical pipeline report, company report or official report of Aphios
2 Anti-amyloidogenic effects of ID1201, the ethanolic extract of the fruits of Melia toosendan, through activation of the phosphatidylinositol 3-kinase/Akt pathway. Environ Toxicol Pharmacol. 2014 Mar;37(2):513-20.
3 Alzheimer's disease drug development pipeline: 2021. Alzheimers Dement (N Y). 2021 May 25;7(1):e12179.